Archives for: October 2012

When the Risk Outweighs the Possible Gain

I read the NYT this morning, as I often do, and paused in reading the article Scant Oversight of Drug Maker in Fatal Meningitis Outbreak. I appreciate the many benefits we have gained from conventional medicine, even many of the benefits from pharmaceuticals, but I can’t help feeling sad when I read an article about [...]